Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder - PubMed (original) (raw)

doi: 10.1176/appi.ajp.2009.09070973. Epub 2010 Apr 1.

Jordan W Smoller, Jayalakshmi Mysore, Mei Sun, Tammy Gillis, Shaun Purcell, Marcella Rietschel, Markus M Nöthen, Stephanie Witt, Wolfgang Maier, Dan V Iosifescu, Patrick Sullivan, A John Rush, Maurizio Fava, Hans Breiter, Marcy Macdonald, James Gusella

Affiliations

Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder

Roy H Perlis et al. Am J Psychiatry. 2010 May.

Abstract

Objective: Presymptomatic individuals with the Huntingtin (HTT) CAG expansion mutation that causes Huntington's disease may have higher levels of depressive symptoms than healthy comparison populations. However, the prevalence of HTT CAG repeat expansions among individuals diagnosed with major depressive disorder has not been established.

Method: This was a case-control genetic association study of HTT CAG allele size in two discovery cohorts of individuals with major depressive disorder and comparison subjects without major depression as well as a replication cohort of individuals with major depression and comparison subjects without major depression.

Results: CAG repeat lengths of 36 or greater were observed in six of 3,054 chromosomes from individuals with major depression, compared with none of 4,155 chromosomes from comparison subjects. In a third cohort, one expanded allele was observed among 1,202 chromosomes in the major depression group, compared with none of 2,678 chromosomes in comparison subjects. No clear pattern of clinical features was shared among individuals with the expanded repeats.

Conclusions: In clinical populations of individuals diagnosed with major depression, approximately 3 in 1,000 carried expanded HTT CAG alleles.

PubMed Disclaimer

Figures

FIGURE 1

FIGURE 1

Distribution of HTT Allele Length in 4,007 Healthy Comparison Subjects and 2,986 Patients With Major Depression

Similar articles

Cited by

References

    1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes (the Huntington’s Disease Collaborative Research Group) Cell. 1993;72:971–983. - PubMed
    1. MacDonald ME, Gines S, Gusella JF, Wheeler VC. Huntington’s disease. Neuromolecular Med. 2003;4:7–20. - PubMed
    1. Semaka A, Creighton S, Warby S, Hayden MR. Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin Genet. 2006;70:283–294. - PubMed
    1. Kirkwood SC, Su JL, Conneally P, Foroud T. Progression of symptoms in the early and middle stages of Huntington disease. Arch Neurol. 2001;58:273–278. - PubMed
    1. Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC Predict-HD Investigators of the Huntington Study Group. Psychiatric symptoms in Huntington’s disease before diagnosis: the Predict-HD study. Biol Psychiatry. 2007;62:1341–1346. - PubMed

Publication types

MeSH terms

Grants and funding

LinkOut - more resources